Could immune checkpoint drugs tame a deadly brain virus?
NCT ID NCT07512518
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether immune checkpoint inhibitors, drugs that help the immune system fight infections, can improve outcomes for people with progressive multifocal leukoencephalopathy (PML), a rare brain virus. Researchers will follow 66 patients over a year, measuring disability, brain scans, and viral levels. The goal is to see if these drugs can control the infection and reduce long-term damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Immune checkpoint inhibitors (drugs that boost the immune system to fight viruses)
- What this could lead to
- If successful, this could point toward a new treatment for progressive multifocal leukoencephalopathy (PML), a rare and often fatal brain infection.
- What could go wrong
- This is a small, early-stage study with only 66 participants, so results may not apply to everyone. Immune checkpoint inhibitors can cause side effects like inflammation or autoimmune reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC VIRAL INFECTION OF THE CENTRAL NERVOUS SYSTEM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an immune booster after lung cancer surgery keep the disease at bay?
- Rare brain infection risk under scrutiny for multiple sclerosis drug ozanimod
- Could a COVID-19 shot boost cancer immunotherapy? a massive study digs into the timing.
- Scientists probe hidden clues to immunotherapy success in endometrial cancer
- New radiation approach aims to boost lung cancer treatment in poor responders
- Study reveals why immunotherapy works differently in liver, lung, and brain tumors